These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18893)

  • 1. Participation of GABA receptors in the short-term activation of striatal tyrosine-3-monooxygenase elicited by neuroleptics.
    Guidotti A; Gale K
    Adv Biochem Psychopharmacol; 1977; 16():455-60. PubMed ID: 18893
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence for a role of nigral gamma-aminobutyric acid and substance P in the haloperidol-induced activation of striatal tyrosine hydroxylase.
    Gale K; Costa E; Toffano G; Hong JS; Guidotti A
    J Pharmacol Exp Ther; 1978 Jul; 206(1):29-37. PubMed ID: 26799
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential effects of gamma-aminobutyric acid (GABA)-elevating agents on the neuroleptic-induced activation of striatal tyrosine-hydroxylase: evidence that di-n-propylacetate augments GABAergic neurotransmission.
    Casu M; Gale K
    J Pharmacol Exp Ther; 1981 Apr; 217(1):177-80. PubMed ID: 6110774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rotational behaviour and striatal dopamine metabolism following unilateral activation of nigral GABA mechanisms: GABA-like modulation of dopaminergic and non-dopaminergic neurons in rat substantia nigra [proceedings].
    Waddington JL
    Br J Pharmacol; 1978 Jun; 63(2):384P. PubMed ID: 566600
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic neuroleptic therapy: tolerance and GABA systems.
    Lloyd KG; Shibuya M; Davidson L; Hornykiewicz O
    Adv Biochem Psychopharmacol; 1977; 16():409-15. PubMed ID: 18890
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic selegiline administration transiently decreases tyrosine hydroxylase activity and mRNA in the rat nigrostriatal pathway.
    Vrana SL; Azzaro AJ; Vrana KE
    Mol Pharmacol; 1992 May; 41(5):839-44. PubMed ID: 1350320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for descending pallido-nigral GABA-containing neurons.
    McGeer PL; Fibiger HC; Maler L; Hattori T; McGeer EG
    Adv Neurol; 1974; 5():153-60. PubMed ID: 4155231
    [No Abstract]   [Full Text] [Related]  

  • 8. GABA-mediated control of rat neostriatal tyrosine hydroxylase revealed by intranigral muscimol.
    Gale KN; Guidotti A
    Nature; 1976 Oct; 263(5579):691-3. PubMed ID: 10528
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental tardive dyskinesia.
    Gunne LM; Häggström JE
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):48-50. PubMed ID: 2858481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of manipulating pallidal and nigral GABA on striatally-mediated head-turning in the rat [proceedings].
    Crossman AR; Lee LA; Slater P
    Br J Pharmacol; 1977 Nov; 61(3):483P. PubMed ID: 563262
    [No Abstract]   [Full Text] [Related]  

  • 11. Striatal tyrosine hydroxylase: comparison of the activation produced by depolarization and dibutyryl-cAMP.
    Simon JR; Roth RH
    Mol Pharmacol; 1979 Jul; 16(1):224-33. PubMed ID: 39245
    [No Abstract]   [Full Text] [Related]  

  • 12. Dopaminergic neurons in explants of substantia nigra in culture.
    Coyle JT; Jacobowitz D; Klein D; Axelrod J
    J Neurobiol; 1973; 4(5):461-70. PubMed ID: 4147763
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of haloperidol and melatonin on the in situ activity of nigrostriatal tyrosine hydroxylase in male Syrian hamsters.
    Vriend J; Dreger L
    Life Sci; 2006 Mar; 78(15):1707-12. PubMed ID: 16263138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary investigation of a process of desensitization on mammalian presynaptic gamma-aminobutyric (GABA) receptors [proceedings].
    Deschenes M; Feltz P; Rouzaire-Dubois B; Kelly JS
    Br J Pharmacol; 1977 Mar; 59(3):487P. PubMed ID: 843725
    [No Abstract]   [Full Text] [Related]  

  • 15. Destruction of post-synaptic dopamine receptors prevents neuroleptic-induced activation of striatal tyrosine hydroxylase but not dopamine synthesis stimulation.
    Di Chiara G; Onali PL; Tissari AH; Porceddu ML; Morelli M; Gessa GL
    Life Sci; 1978 Aug; 23(7):691-6. PubMed ID: 29204
    [No Abstract]   [Full Text] [Related]  

  • 16. Possible involvement of GABA in the central actions of benzodiazepines.
    Haefely W; Kulcsár A; Möhler H; Pieri L; Polc P; Schaffner R
    Adv Biochem Psychopharmacol; 1975; (14):131-51. PubMed ID: 242199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurochemical sequelae of kainate injections in corpus striatum and substantia nigra of the rat.
    Schwarcz R; Coyle JT
    Life Sci; 1977 Feb; 20(3):431-6. PubMed ID: 14287
    [No Abstract]   [Full Text] [Related]  

  • 18. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
    Yamamoto BK; Nash JF; Gudelsky GA
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1063-70. PubMed ID: 7791076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nitric oxide synthase inhibitor decreases 6-hydroxydopamine effects on tyrosine hydroxylase and neuronal nitric oxide synthase in the rat nigrostriatal pathway.
    Gomes MZ; Raisman-Vozari R; Del Bel EA
    Brain Res; 2008 Apr; 1203():160-9. PubMed ID: 18313645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine hydroxylase mRNA and protein are down-regulated by chronic clozapine in both the mesocorticolimbic and the nigrostriatal systems.
    Tejedor-Real P; Faucon Biguet N; Dumas S; Mallet J
    J Neurosci Res; 2003 Apr; 72(1):105-15. PubMed ID: 12645084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.